Filing Details

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

AEON Global Health Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

00774U107

(CUSIP Number)

November 23, 2018

(Date of Event Which Requires Filing of this Statement)

 

1	NAMES OF REPORTING PERSONS
	JUSTIN B. BORUS
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			1,462,224
		6	SHARED VOTING POWER
			0
		7	SOLE DISPOSITIVE POWER
			1,462,224
		8	SHARED DISPOSITIVE POWER
			0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,462,224
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	17.4%
12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN/HC

 

 

 

1	NAMES OF REPORTING PERSONS
	IBEX MICROCAP FUND LLLP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			1,461,391
		6	SHARED VOTING POWER
			0
		7	SOLE DISPOSITIVE POWER
			1,461,391
		8	SHARED DISPOSITIVE POWER
			0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,461,391
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	17.4%
12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

 

 

 

1	NAMES OF REPORTING PERSONS
	LAZARUS MACRO MICRO PARTNERS LLLP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			833
		6	SHARED VOTING POWER
			0
		7	SOLE DISPOSITIVE POWER
			833
		8	SHARED DISPOSITIVE POWER
			0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	833
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	0.01%
12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

 

 

(a)         Name of Issuer:

AEON Global Health Corp. (the "Issuer")

(b)         Address of Issuer's Principal Executive Office:

2225 Centennial Drive

Gainesville, GA  30504

(a)         Name of Person Filing:

Ibex Investors LLC ("Ibex")

Justin B. Borus

Ibex Microcap Fund LLLP ("Ibex Microcap")

Lazarus Macro Micro Partners LLLP ("Macro Micro" and together with Ibex Microcap, Ibex and Mr. Borus, the "Reporting Persons")

(b)         Address of Principal Business Office or, if none, Residence:

The business address of each of the Reporting Persons is c/o Ibex Investors LLC, 3200 Cherry Creek South Drive, Suite 670, Denver, Colorado 80209.

(c)         Citizenship:

Reference is made to Item 4 of pages 2–5 of this Schedule 13G (this "Schedule"), which Items are incorporated by reference herein.

(d)         Title of Class of Securities:

Common Stock, $.001 par value per share

(e)         CUSIP Number:

00774U107

 

 

Reference is hereby made to Items 5-9 and 11 of pages 2 - 5 of this Schedule, which Items are incorporated by reference herein.  The securities reported on this Schedule consist of 452,974 shares of common stock, 200,000 shares of Series D Preferred Stock that are convertible into 204,679 shares of common stock and warrants to purchase 803,738 shares of common stock exercisable within 60 days of the date of this filing held by Ibex Microcap.  The securities reported on this Schedule 13G that are held by Macro Micro consists of 833 shares of common stock.  Ibex is the investment adviser and general partner of Ibex Microcap and Macro Micro, and consequently may be deemed to have voting control and investment discretion over the securities owned by Ibex Microcap and Macro Micro.  Justin B. Borus is the manager of Ibex.  As a result, Mr. Borus may be deemed to be the beneficial owner of any shares deemed to be beneficially owned by Ibex.  The foregoing should not be construed in and of itself as an admission by Ibex or Mr. Borus as to beneficial ownership of the shares owned by Ibex Microcap and Macro Micro.  Each of Ibex and Mr. Borus disclaims beneficial ownership of the securities set forth in this Schedule 13G except to the extent of its or his pecuniary interests therein.

The calculation of percentage of beneficial ownership in Item 11 of pages 2-5 was calculated based on 7,383,706 shares of common stock outstanding as of October 25, 2018 as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 9, 2018.